Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials
Year: 2025
Type: article
Language: en
Topic: Ethics in Clinical Research
Authors and affiliations:
raw_author_name: Fen Saj
raw_affiliation_strings: Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Felicity K. Namayanja
raw_affiliation_strings: Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Lianchun Xiao
raw_affiliation_strings: Department of Biostatistics The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Mitesh J Borad
raw_affiliation_strings: Division of Hematology and Oncology Department of Medicine Mayo Clinic  Scottsdale Arizona USA
Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona, USA
raw_author_name: Robin Kate Kelley
raw_affiliation_strings: Division of Hematology/Oncology Helen Diller Family Comprehensive Cancer Center University of California‐San Francisco  San Francisco California USA
Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California, USA
raw_author_name: Lipika Goyal
raw_affiliation_strings: Department of Medicine Division of Hematology and Oncology Stanford Cancer Center  Palo Alto California USA
Department of Medicine, Division of Hematology and Oncology, Stanford Cancer Center, Palo Alto, California, USA
raw_author_name: Nilofer S. Azad
raw_affiliation_strings: Department of Oncology Sidney Kimmel Comprehensive Cancer Center The Johns Hopkins University School of Medicine  Baltimore Maryland USA
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
raw_author_name: Melinda Bachini
raw_affiliation_strings: Division of Cancer Sciences University of Manchester  Manchester UK
The Cholangiocarcinoma Foundation  Herriman Utah USA
The Cholangiocarcinoma Foundation, Herriman, Utah, USA
Division of Cancer Sciences, University of Manchester, Manchester, UK
raw_author_name: Stacie Lindsey
raw_affiliation_strings: Division of Cancer Sciences University of Manchester  Manchester UK
The Cholangiocarcinoma Foundation  Herriman Utah USA
Division of Cancer Sciences, University of Manchester, Manchester, UK
The Cholangiocarcinoma Foundation, Herriman, Utah, USA
raw_author_name: Shubham Pant
raw_affiliation_strings: Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Juan W. Valle
raw_affiliation_strings: Division of Cancer Sciences University of Manchester  Manchester UK
The Cholangiocarcinoma Foundation  Herriman Utah USA
The Cholangiocarcinoma Foundation, Herriman, Utah, USA
Division of Cancer Sciences, University of Manchester, Manchester, UK
raw_author_name: Lola A Fashoyin‐Aje
raw_affiliation_strings: Oncology Center of Excellence US Food and Drug Administration  Silver Spring Maryland USA
Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA
raw_author_name: Milind Javle
raw_affiliation_strings: Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA